PET/Computed Tomography: Laryngeal and Hypopharyngeal Cancers.

Journal Article (Journal Article;Review)

Treatment of laryngeal and hypopharyngeal tumors with surgery, radiation therapy, and chemotherapy is aimed at improving survival and preserving function. PET with fluorodeoxyglucose F 18 (18F FDG-PET)/computed tomography is the standard of care and an integral part of staging and treatment response assessment in patients with laryngeal and hypopharyngeal cancers. Knowledge of cross-sectional laryngeal and hypopharyngeal anatomy, expected patterns of tumor spread, and awareness of physiologic FDG uptake in head and neck structures is essential for accurate TNM staging. 18F FDG-PET/computed tomography is superior to anatomic imaging in identifying posttreatment local, regional, and distant tumor recurrence.

Full Text

Duke Authors

Cited Authors

  • Kandathil, A; Subramaniam, RM

Published Date

  • April 2022

Published In

Volume / Issue

  • 17 / 2

Start / End Page

  • 235 - 248

PubMed ID

  • 35260366

Electronic International Standard Serial Number (EISSN)

  • 1879-9809

Digital Object Identifier (DOI)

  • 10.1016/j.cpet.2021.12.009


  • eng

Conference Location

  • United States